| 发明名称 |
(hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| 摘要 |
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. |
| 申请公布号 |
AU2012324805(A1) |
申请公布日期 |
2014.04.03 |
| 申请号 |
AU20120324805 |
申请日期 |
2012.10.22 |
| 申请人 |
ORYZON GENOMICS, S.A. |
发明人 |
ORTEGA MUNOZ, ALBERTO;FYFE, MATHEW COLIN THOR;MARTINELL PEDEMONTE, MARC;ESTIARTE MARTINEZ, MARIA DE LOS ANGELES;VALLS VIDAL, NURIA;KURZ, GUIDO;CASTRO PALOMINO LARIA, JULIO CESAR |
| 分类号 |
C07D213/74;A61K31/135;A61P25/00;A61P31/12;A61P35/00;C07C211/35 |
主分类号 |
C07D213/74 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
